The overarching objective of Immune-Image is to develop a novel non-invasive imaging strategy for assessing immune cell activation and dynamics in oncology and inflammatory disease, in animal models and in patients. Immune-Image will (a) develop, optimise and validate existing and novel immune cell-specific imaging probes, (b) establish imaging protocols, hybrid imaging workflows and imaging software, and (c) prepare the regulatory framework for clinical trials using novel immune imaging approaches for developing, selecting and monitoring immunotherapies.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831514. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.Read more
All uploads acknowledging the Immune-Image project are accepted.